Sales decline 66.51% to Rs 2.92 crore
Net Loss of Parenteral Drugs (India) reported to Rs 32.22 crore in the quarter ended June 2020 as against net loss of Rs 27.69 crore during the previous quarter ended June 2019. Sales declined 66.51% to Rs 2.92 crore in the quarter ended June 2020 as against Rs 8.72 crore during the previous quarter ended June 2019. ParticularsQuarter EndedJun. 2020Jun. 2019% Var.Sales2.928.72 -67 OPM %-199.66-45.53 -PBDT-35.67-29.95 -19 PBT-40.00-34.30 -17 NP-32.22-27.69 -16Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)